As per Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s news release on 2016-08-08, its shareholders will get cash dividend of $0.289 per share. The recent press release updated on the record date and payout date, which stands at 2016-08-22 and 2016-09-08, respectively.
The stock will commence trading ex-dividend from 2016-08-18, until, which the shareholders are compelled to keep the holdings so as to qualify for the dividend. Evaluating the dividend distribution mode, it was noted that last year Teva Pharmaceutical Industries Limited (NYSE:TEVA) disbursed $0.289 in dividend compared to distribution of $0.289, a year ago.
It highlights a sharp difference in cash payouts of the two years. This shows a major deviation of 0.7903%.
The sell-side market professionals who track the firm’s financial and technical parameters have estimated Teva Pharmaceutical Industries Limited (NYSE:TEVA) to attain a price target of $72.055. It is an average estimate figure given by 15 analysts tracking the stock. The estimates disclosed that the stock can move up on the chart and hit a high of $100. The low price range is set at $57 for next year while the arithmetic mean is seen at 1.59.
Eyeing Earnings Teva Pharmaceutical Industries Limited (NYSE:TEVA) is likely to post quarterly numbers around 2016-11-15 for the quarter ending 2016-09-30. The quarterly EPS projection is set at $1.32 for the period ending on 2016-09-30.
In last quarter ended 2015-12-31, Teva Pharmaceutical Industries Limited (NYSE:TEVA) earnings came at $1.25 suggesting a deviation of $0.07. The brokerages targeted EPS of $1.18 for the quarter.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...